| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 7861954 | Journal of Controlled Release | 2016 | 28 Pages |
Abstract
Aptamer-antibody hybrid complex: Because the oligobody requires only a single antibody and utilizes a simple antigen-antibody reaction, it could offer the benefits of aptamers and antibodies, and may be a potentially valuable tool for cancer therapeutics.155
Related Topics
Physical Sciences and Engineering
Materials Science
Biomaterials
Authors
Kyun Heo, Sung-Won Min, Ho Jin Sung, Han Gyul Kim, Hyun Jung Kim, Yun Hee Kim, Beom Kyu Choi, Sewoon Han, Seok Chung, Eun Sook Lee, Junho Chung, In-Hoo Kim,